Black Rock Inc. Seres Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,762,157 shares of MCRB stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,762,157
Previous 6,825,399
74.18%
Holding current value
$1.62 Million
Previous $5.26 Million
75.87%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MCRB
# of Institutions
82Shares Held
40.5MCall Options Held
304KPut Options Held
471K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$21.3 Million3.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.06MShares$5.58 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.39MShares$1.28 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.19MShares$1.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.02MShares$940,2000.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $114M
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...